Navigation Links
Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg
Date:4/24/2008

BEIJING, April 24 /Xinhua-PRNewswire-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a pharmaceutical company in the People's Republic of China ("PRC"), today announced the resignation of Mel Rothberg from the Company's board of directors, effective April 21, 2008, for personal reasons.

Mr. Rothberg served as a director since August 2006. Following his resignation, he will continue to serve as independent consultant to the Company, where he will provide advice and counsel on business development issues as they relate to Lotus' corporate governance and pharmaceutical pipeline. Mr. Rothberg has extensive experience in senior management positions with pharmaceutical and medical device companies with operations worldwide.

"In his tenure on our board, Mel Rothberg made an outstanding contribution to Lotus' corporate governance and development," said Dr. Zhongyi Liu, Chairman and Chief Executive Officer of Lotus. "We look forward to working with him in the future as an independent consultant."

Following Mr. Rothberg's departure, Lotus' board is comprised of seven directors, two of whom are independent.

About Lotus Pharmaceuticals, Inc.

Lotus Pharmaceuticals, Inc. ("Lotus") controls and operates Liangfang Pharmaceutical, Ltd. ("Liangfang") and Enzhe Jiashi Pharmaceutical, Ltd. ("Enzhe"), two Chinese pharmaceutical companies located in Beijing (together "Lotus East"). Lotus East is a comprehensive enterprise, which deals in an integration of the production, trade, sales and marketing of pharmaceuticals. The Company possesses some of the most advanced pharmaceutical-production equipment used in China, workshops authenticated by the National GMP, a suite of various medicines produced by Lotus East, and a number of high-tech personnel. Lotus East has business and office facilities of 2,000 square meters, warehouse of 1,000 square meters and operates ten retail pharmacies in the Beijing a
'/>"/>

SOURCE Lotus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results
2. Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2007 Results
3. Lotus Pharmaceuticals Raises $5 Million in Private Placement
4. Lotus Pharmaceuticals, Inc. Implements Environmentally-friendly Cost Saving Strategies
5. Lotus Blossom Consulting Announces E-Book on Infertility Treatment Financing
6. Aida Pharmaceuticals, Inc. Announces Availability of Downloadable Corporate Synopsis on its Website
7. Aida Pharmaceuticals, Inc. Announces New Antibiotic Drug Under Development
8. Bayer HealthCare Pharmaceuticals, Amerinet Extend Contrast Media Agreement
9. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
10. Barr Pharmaceuticals, Inc. Executive Bios
11. Alseres Pharmaceuticals, Inc. Raises $5 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... 13, 2014 Fuel additives are chemicals, ... diesel, jet fuel, kerosene, and so on, in order ... for reducing the corrosion effects caused by fuels and ... to any fuel, provide economies of scale in the ... the overall cost of the fuel products. , The ...
(Date:7/13/2014)... 13, 2014 According to a ... Computing Market by Component (processor, GPU, DSP, connectivity), ... Medical), and Geography - Forecast and Analysis to ... Processing & Computing Market is expected to reach ... of 20.75% from 2014 to 2020. , Browse ...
(Date:7/13/2014)... MarketsandMarkets recently conducted a study ... Scanning; 3D rendering; Layout and Animation; Image Reconstruction]: ... 2018)”, which analyzes and studies the major market ... Europe, Eastern Europe, Middle East and Africa, Asia-Pacific ... competitive landscape of the 3D imaging market, providing ...
(Date:7/13/2014)... (PRWEB) July 13, 2014 A Massachusetts ... to the cancer risks associated with power morcellators ( ... their story to federal regulators, as they presented poignant ... Food & Drug Administration (FDA) advisory panel meeting convened ... According to the Rochester Democrat and Chronicle, Dr. Hooman ...
(Date:7/13/2014)... HealthDay Reporter FRIDAY, July 11, ... for people with diabetes is being developed to measure sugar ... report. Scientists at Brown University in Providence, R.I., created ... uses light, metal and a special enzyme that changes color ... have to prick their fingers to draw blood to check ...
Breaking Medicine News(10 mins):Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 2Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 3Health News:North America Fuel Additives Market is Expected to Reach $8,100 Million by 2017 - New Report by MicroMarket Monitor 4Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 4Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 2Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 3Health News:3D Imaging Market Worth $9.82 Billion By 2018 - Report by MarketsandMarkets 4Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 2Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 3Health News:Couple Who Brought Attention to Morcellator Cancer Risks Testify on Second Day of FDA Advisory Panel Meeting, Bernstein Liebhard LLP Reports 4Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 2Health News:Saliva Test Might Someday Replace Needle Prick for Diabetics 3
... lung cancer (NSCLC), the most common form of lung ... a small group of patients can also be helped ... published in BioMed Central,s open access journal BMC ... factor receptor (EGFR) using RNAi, alongside TKI (or antibody ...
... kind, a consortium of investigators from 13 countries led the ... the Catholic University of Leuven, Belgium in Europe, found that ... likelihood of leaving also had patients who were more satisfied ... The study was released today in the current issue of ...
... HealthDay Reporter , TUESDAY, March 20 (HealthDay News) -- ... epinephrine -- adrenaline -- might do more harm than ... of hundreds of thousands of cases. Japanese researchers ... likely to survive one month, compared with those who ...
... such as kidney failure and endocrine tumors are among ... the common pain relievers in your medicine cabinet be ... Tel Aviv University,s Sackler Faculty of Medicine and the ... are underlying causes of hypertension, which is a major ...
... , TUESDAY, March 20 (HealthDay News) -- Insects ... Chagas disease are well-established and feeding on human blood in ... What remains a mystery, however, is why the insects ... a serious condition that can lead to life-threatening digestive and ...
... , TUESDAY, March 20 (HealthDay News) -- The ... of altitude sickness, according to a new study. ... among the symptoms of altitude sickness, which affects more ... elevations each year to ski, hike or camp. ...
Cached Medicine News:Health News:Double whammy: RNAi enhances lung cancer therapy 2Health News:International research finds quality and safety problems in hospitals throughout 13 countries 2Health News:Adrenaline Therapy for Cardiac Arrest Linked to Worse Outcomes 2Health News:Adrenaline Therapy for Cardiac Arrest Linked to Worse Outcomes 3Health News:Pain relievers could be spiking your blood pressure 2Health News:Insects Behind Chagas Disease Are Feeding on Humans in the U.S. 2Health News:Ibuprofen May Ward Off Altitude Sickness 2
(Date:7/13/2014)...  Eli Lilly and Company (NYSE: ... study in genetically engineered mice examining combination therapy ... N3pG and beta-secretase inhibitor BACE (LY2811376). Data results ... removing clumps of amyloid-beta protein in the brain ... to Alzheimer,s disease (AD) – than use of ...
(Date:7/11/2014)... ANGELES , July 11, 2014 /PRNewswire-iReach/ -- ... e-liquid, a vegetable-glycol solution for use in portable ... of the active ingredients in cannabis, cannabidiol offers ... personal vaporizer devices, and other vaporizer technology. ... Cannabis naturally contains 483 different compounds which ...
(Date:7/11/2014)... HILL, N.C. , July 11, 2014 /PRNewswire/ ... of pharmaceutical marketing and, consequently, organizations are turning ... for patients. As part of this ... it,s important to educate, communicate and engage patients ... disease awareness to patient empowerment. By mapping the ...
Breaking Medicine Technology:New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 2New Data Shows Combination Therapy is More Effective than Monotherapy in Removing Beta-Amyloid Plaques from the Brains of Mice 3VAPETEK Releases CBD-Infused eLiquid For The Consumer Market 2New Study Uses Six-Step Patient Journey as Framework for Consumer-Focused Marketing Opportunities 2
... , , SILVER SPRING, Md. , Feb. ... approved Xiaflex (collagenase clostridium histolyticum) as the first drug to ... can affect a person,s ability to straighten and properly use ... affects the connective tissue found beneath the skin in the ...
... 2 Vermillion, Inc. (Pink Sheets: VRML) today announced the reappointment ... Company and Eric T. Fung , MD, PhD as Senior Vice ... announced appointment of William C. Wallen , PhD to the Board ... Chair of the Board of Directors. , "Both Dr. Fung and I ...
Cached Medicine Technology:FDA Approves Xiaflex for Debilitating Hand Condition 2Vermillion Announces the Reappointment of Officers and Confirmation of Director 2Vermillion Announces the Reappointment of Officers and Confirmation of Director 3Vermillion Announces the Reappointment of Officers and Confirmation of Director 4
Intermittent catheter...
Intermittent catheter...
Intermittent catheter...
... The new Finnpipette Focus from Thermo Labsystems ... uncompromising performance. Advanced features such as ... fine volume adjustment on microvolumes help to ... single channel pipettes. The new interchangeable handle ...
Medicine Products: